As of 2024-12-15, the Relative Valuation of Bioharvest Sciences Inc (BHSC.CN) is (6.13) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 8.92 CAD, the upside of Bioharvest Sciences Inc based on Relative Valuation is -168.7%.
The range of the Relative Valuation is (7.95) - (4.45) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.0x - 3.3x | 3.1x |
| Forward P/E multiples | 6.0x - 19.4x | 6.1x |
| Fair Price | (7.95) - (4.45) | (6.13) |
| Upside | -189.1% - -149.9% | -168.7% |
| Date | P/E |
| 2024-12-11 | -9.34 |
| 2024-12-10 | -9.29 |
| 2024-12-09 | -9.34 |
| 2024-12-06 | -9.24 |
| 2024-12-05 | -8.80 |
| 2024-12-04 | -9.13 |
| 2024-12-03 | -9.34 |
| 2024-12-02 | -9.29 |
| 2024-11-27 | -9.29 |
| 2024-11-26 | -9.29 |
| 2024-11-25 | -9.13 |
| 2024-11-22 | -9.23 |
| 2024-11-21 | -9.18 |
| 2024-11-20 | -9.31 |
| 2024-11-19 | -9.34 |
| 2024-11-18 | -9.34 |
| 2024-11-15 | -9.05 |
| 2024-11-14 | -8.97 |
| 2024-11-13 | -8.97 |
| 2024-11-12 | -8.53 |
| 2024-11-11 | -8.54 |
| 2024-11-08 | -8.33 |
| 2024-11-07 | -8.22 |
| 2024-11-06 | -7.37 |
| 2024-11-05 | -7.21 |
| 2024-11-04 | -7.08 |
| 2024-11-01 | -7.21 |
| 2024-10-31 | -7.21 |
| 2024-10-30 | -7.21 |
| 2024-10-29 | -7.21 |
| 2024-10-28 | -7.02 |
| 2024-10-25 | -7.21 |
| 2024-10-24 | -7.21 |
| 2024-10-23 | -7.05 |
| 2024-10-22 | -7.21 |
| 2024-10-21 | -7.31 |
| 2024-10-18 | -7.19 |
| 2024-10-17 | -7.37 |
| 2024-10-16 | -7.63 |
| 2024-10-15 | -7.78 |
| 2024-10-09 | -7.90 |
| 2024-10-08 | -7.79 |
| 2024-10-07 | -7.90 |
| 2024-10-03 | -8.12 |
| 2024-10-02 | -8.12 |
| 2024-10-01 | -8.12 |
| 2024-09-27 | -8.28 |
| 2024-09-26 | -8.06 |
| 2024-09-25 | -8.07 |
| 2024-09-24 | -8.12 |